天弘中证医药主题指数增强C(012402)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
3,919,572.27 |
-17,292,027.67 |
-20,664,212.04 |
-7,385,792.43 |
| 利息合计 |
8,386.44 |
22,480.17 |
11,365.86 |
28,671.46 |
| 其中：存款利息收入 |
8,386.44 |
22,480.17 |
11,365.86 |
28,671.46 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-599,944.70 |
-19,292,103.79 |
-11,526,404.25 |
-7,993,631.95 |
| 其中：股票投资收益 |
-1,360,600.92 |
-21,071,223.45 |
-12,661,540.83 |
-9,428,057.65 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
521.65 |
26,433.50 |
16,590.70 |
38,313.19 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
760,134.57 |
1,752,686.16 |
1,118,545.88 |
1,396,112.51 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
4,483,224.55 |
1,866,801.47 |
-9,181,004.67 |
446,213.00 |
| 其他收入 |
27,905.98 |
110,794.48 |
31,831.02 |
132,955.06 |
| 费用 |
423,921.67 |
1,017,900.78 |
534,179.08 |
1,246,171.25 |
| 管理人报酬 |
249,776.31 |
591,784.00 |
306,404.98 |
723,760.67 |
| 基金托管费 |
41,629.37 |
98,630.59 |
51,067.43 |
120,626.82 |
| 销售服务费 |
70,856.11 |
163,214.73 |
85,148.33 |
216,099.42 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
61,659.88 |
164,271.41 |
91,558.31 |
185,684.30 |
| 利润总额 |
3,495,650.60 |
-18,309,928.45 |
-21,198,391.12 |
-8,631,963.68 |
微信公众号
证券之星APP
基本资料
